Clinical Trial Update: A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors. [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating ERAS-4001 in patients with advanced or metastatic solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• ERAS-4001

Snippet

Sponsor: Erasca, Inc. | Conditions: Metastatic Solid Tumors | Phase 1 | Status: RECRUITING